The healthcare system in the United Arab Emirates (UAE) is viewed not as an isolated sector, but as one closely linked to the country's broader national goals, including economic strength, quality of life, and the ability to remain resilient in a rapidly changing world.
National Ambitions and Partnership
This approach is reflected in the We the UAE 2031 strategy, where healthcare is defined as a driver of national progress with a clear goal—to be among the world leaders in medical care quality. For the private sector, this means not just functioning within the system, but actively participating in its long-term strengthening.
Progress in healthcare is achieved through collaboration: regulators create protective frameworks for patients and ensure trust, while industry partners bring innovation, scale, and operational flexibility. This coordinated interaction makes healthcare systems more robust, accelerates the adoption of innovations, and allows patients to receive solutions that meet real needs.
MSD's Activities in the UAE
MSD, known as Merck & Co. Inc., is a global research-oriented biopharmaceutical company that develops medicines and vaccines to address serious global health challenges. MSD's partnership with the UAE spans over four decades, during which time the company has focused on delivering vaccine and medicine innovations to patients in the UAE and the region, ensuring supply continuity, and investing in local capabilities to strengthen the entire healthcare ecosystem.
In the last five years, the focus of MSD's work has intensified due to the acceleration of innovation. The company has expanded partnerships into new areas, paying greater attention to developing expertise, building capacity, and supporting the next phase of healthcare transformation in the UAE.
Supply Chain Resilience
As global pressure mounts on pharmaceutical supply chains, resilience has become a shared priority. The UAE has established itself as a reliable hub for regional and international supplies, supported by a developed regulatory environment and close interaction between government bodies and industry. Through such cooperation, operational plans can dynamically respond to demand changes, maintaining market stability and continuity of care for patients.
The Role of Policy and Collaboration
The Emirates Drug Establishment (EDE) has fostered an environment where efficacy and safety go hand in hand, allowing innovations to reach patients without compromising trust. This balance gives healthcare partners confidence to plan, invest, and react effectively even during periods of uncertainty.
Partnership in the UAE goes beyond mere supply. In Abu Dhabi, MSD's collaboration with the Department of Health has become broader and more future-oriented. In 2022, both parties signed a memorandum of understanding covering scientific research, education, and innovation. In 2023, a UAE delegation visited MSD Research Laboratories in Boston, reinforcing the shared commitment to science, capacity building, and the system's long-term readiness. Recently, in 2024, a non-binding memorandum of understanding was signed focusing on lung cancer clinical trials.
Innovation and Patient Care
Innovations continue to shape healthcare delivery and patient care, and MSD continues to develop its portfolio in promising areas, reflecting a commitment to meeting evolving patient needs. National efforts in disease prediction and data-driven healthcare enable the application of more precise and personalized treatment approaches.
Patients are central to this progress, and engaging them through targeted awareness campaigns promoting early detection remains key. As part of flagship initiatives like the EMBRACE breast cancer awareness campaign, MSD expands its influence annually. Over the past five years, the company has collaborated with various partners, including the Ministry of Health and Population, the Abu Dhabi Department of Health, Friends of Cancer Patients, Emirates Airlines, Deliveroo, MAF Group, and others, united by the common goal of advancing early detection and diagnosis of breast cancer.
Drug Access and Support
Regarding prevention and drug access, MSD's contribution has been significant. Prevention has long been a national priority in the UAE, and MSD has supported these efforts by introducing innovative vaccines and engaging with healthcare stakeholders. These measures have helped reduce the burden of diseases such as HPV-related conditions through proactive care.
Well-designed patient support programs, aligned with national standards, underscore the importance of coordination within the healthcare ecosystem to achieve tangible results. They play a key role in improving health equity and enhancing access to medications, supporting the UAE's national health agenda. Concurrently, through programs such as TaPhaol for pulmonary arterial hypertension and AWN for oncology patients, MSD has launched landmark initiatives in collaboration with partners like Friends of Cancer Patients and the Emirates Oncology Society, a long-standing strategic partner with whom they work closely with healthcare professionals to ensure high-quality oncological care in the region.
Scale of Industry Coordination
Industry associations, regulators, manufacturers, and logistics partners join forces to align supply with demand and anticipate emerging needs. This collaborative approach not only strengthens the readiness of the healthcare system but also solidifies the UAE's status as a leading regional and global healthcare center.
Future Prospects in the UAE
Looking ahead, MSD's commitment to the UAE remains long-term. The company will continue to invest in partnerships that support innovation, strengthen supply resilience, and develop local expertise so that medicines and vaccines are available to patients when needed most. Since healthcare progress is determined not only by today's achievements but also by how well a country is prepared for tomorrow, this preparedness in the UAE is being built steadily, collaboratively, and with a clear vision for a stronger, more sustainable, and viable healthcare future.